IL49652A0 - Pharmaceutical compositions containing flunisolide for treating respiratory diseases - Google Patents

Pharmaceutical compositions containing flunisolide for treating respiratory diseases

Info

Publication number
IL49652A0
IL49652A0 IL49652A IL4965276A IL49652A0 IL 49652 A0 IL49652 A0 IL 49652A0 IL 49652 A IL49652 A IL 49652A IL 4965276 A IL4965276 A IL 4965276A IL 49652 A0 IL49652 A0 IL 49652A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
respiratory diseases
treating respiratory
flunisolide
Prior art date
Application number
IL49652A
Other versions
IL49652A (en
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of IL49652A0 publication Critical patent/IL49652A0/en
Publication of IL49652A publication Critical patent/IL49652A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
IL49652A 1975-05-27 1976-05-25 Pharmaceutical compositions containing flunisolide for treating respiratory deseases IL49652A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58130075A 1975-05-27 1975-05-27
US58130175A 1975-05-27 1975-05-27

Publications (2)

Publication Number Publication Date
IL49652A0 true IL49652A0 (en) 1976-07-30
IL49652A IL49652A (en) 1979-05-31

Family

ID=27078279

Family Applications (1)

Application Number Title Priority Date Filing Date
IL49652A IL49652A (en) 1975-05-27 1976-05-25 Pharmaceutical compositions containing flunisolide for treating respiratory deseases

Country Status (15)

Country Link
JP (1) JPS51144719A (en)
AT (1) AT357702B (en)
AU (1) AU506080B2 (en)
CA (1) CA1075228A (en)
DE (2) DE2661037C2 (en)
ES (1) ES448220A1 (en)
FR (1) FR2361900A1 (en)
GB (1) GB1525181A (en)
HK (1) HK8580A (en)
IL (1) IL49652A (en)
MX (1) MX3864E (en)
MY (1) MY8000275A (en)
NL (1) NL191234C (en)
NZ (1) NZ180946A (en)
SE (1) SE421426B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193778A (en) * 1979-05-21 1982-03-16 Syntex Corp Preparing a crystalline form of flunisolide
ATE3774T1 (en) * 1980-05-02 1983-06-15 Schering Corporation BECLOMETHASONE ESTER SOLVATE, PROCESS FOR THEIR PREPARATION AND PREPARATION OF A FORMULATION.
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
US5707634A (en) * 1988-10-05 1998-01-13 Pharmacia & Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
EP0437451B1 (en) * 1988-10-05 1993-06-09 The Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
DE4003272A1 (en) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg NEW GAS MIXTURES AND THEIR USE IN MEDICINE PREPARATIONS
IL122752A (en) * 1995-06-27 2001-07-24 Boehringer Ingelheim Kg Stable compositions for generating propellant-free aerosols
DE19653969A1 (en) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg New aqueous pharmaceutical preparation for the production of propellant-free aerosols
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (en) 1998-11-25 2004-03-15 Chiesi Farma Spa Pressure metered dose inhaler.
US6715485B1 (en) * 1999-03-03 2004-04-06 Optinose As Nasal delivery device
IT1313553B1 (en) * 1999-07-23 2002-09-09 Chiesi Farma Spa OPTIMIZED FORMULATIONS CONSTITUTED BY SOLUTIONS OF STEROIDS GIVEN BY INHALATION.
IT1317846B1 (en) 2000-02-22 2003-07-15 Chiesi Farma Spa FORMULATIONS CONTAINING AN ANTICOLINERGIC DRUG FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE BRONCOPNEUMOPATHY.
AU5070100A (en) 2000-05-22 2001-12-03 Chiesi Farma Spa Stable pharmaceutical solution formulations for pressurised metered dose inhalers
EP1273292B1 (en) 2001-07-02 2004-05-26 CHIESI FARMACEUTICI S.p.A. Optimised formulation of tobramycin for aerosolization
JP4632687B2 (en) * 2003-04-25 2011-02-16 ロート製薬株式会社 Nasal drops
JP5238779B2 (en) * 2003-04-25 2013-07-17 ロート製薬株式会社 Nasal drops
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
CN105188758A (en) * 2013-03-15 2015-12-23 梅迪奇斯医药公司 Topical compositions of flunisolide and methods of treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126375A (en) 1964-03-24 Chioacyl
GB933868A (en) * 1958-12-08 1963-08-14 American Cyanamid Co Process for fluorinating steroids
US3282791A (en) 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
US3592930A (en) * 1968-07-19 1971-07-13 Syntex Corp Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
FR2038105A1 (en) * 1969-04-01 1971-01-08 Syntex Corp LOCAL ANTI-INFLAMMATORY COMPOSITION AND ITS INSTRUCTIONS FOR USE
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
DE2332663C2 (en) 1973-06-23 1986-07-31 Schering AG, 1000 Berlin und 4709 Bergkamen Use of corticosteroid active ingredients for inhalation therapy
US3934013A (en) 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition

Also Published As

Publication number Publication date
NZ180946A (en) 1978-07-28
DE2661037C2 (en) 1989-04-06
DE2624924A1 (en) 1977-12-15
JPS51144719A (en) 1976-12-13
HK8580A (en) 1980-03-14
NL191234C (en) 1995-04-03
MX3864E (en) 1981-08-26
FR2361900A1 (en) 1978-03-17
NL7605699A (en) 1976-11-30
JPS6247880B2 (en) 1987-10-09
NL191234B (en) 1994-11-01
SE421426B (en) 1981-12-21
ATA388376A (en) 1979-12-15
DE2624924C2 (en) 1986-11-27
CA1075228A (en) 1980-04-08
ES448220A1 (en) 1977-11-01
IL49652A (en) 1979-05-31
AU506080B2 (en) 1979-12-13
AU1430176A (en) 1977-12-01
FR2361900B1 (en) 1979-04-13
AT357702B (en) 1980-07-25
SE7605927L (en) 1976-11-28
MY8000275A (en) 1980-12-31
GB1525181A (en) 1978-09-20

Similar Documents

Publication Publication Date Title
IL49652A0 (en) Pharmaceutical compositions containing flunisolide for treating respiratory diseases
IL47952A (en) Device for the inhalation of medicaments
JPS5233399A (en) Patient*s respirator
PH14489A (en) Manufacture of pharmaceutical dosage form
PH17318A (en) Manufacture of pharmaceutical unit dosage forms
GB1524578A (en) Aminobenzoamide compounds and pharmaceutical compositions containing them
IL51096A0 (en) Novel pharmaceutical dosage form
ZA761131B (en) A pharmaceutical composition for treating fungal diseases
HK42382A (en) Pharmaceutical compositions
JPS5215826A (en) Medical composition
IL49122A (en) L-pyroglutamyl-l-histidyl-3-alkyl-prolineamide processes for their preparation and therapeutic compositions containing the same
GR60551B (en) Pharmaceutical compositions containing heterocolloidal debrycin and process for the preparation thereof
ZA761880B (en) New pharmaceutical compositions
ZA767215B (en) Pharmaceutical compositions
GB1552416A (en) Pharmaceutical compositions
GB1539031A (en) Pharmaceutical compositions
JPS5236892A (en) Antiidecaying enamel source treatment composition
IL48937A0 (en) New 13-ethinyl-steroids,their manufacture and pharmaceutical compositions containing them
IL50430A0 (en) New 2,4-diamino-5-benzylpyrimidines process for their preparation and pharmaceutical compositions containing these compounds
ZA75607B (en) Pharmaceutical composition for the treatment of cancer
JPS51118822A (en) Human prealbumin containing pharmaceutical composition
IL46985A (en) Pharmaceutical compositions containing certain secondary or tertiary n-cyclohexyl-benzyl amines for the treatment of ulcers
PH13453A (en) A flunisolide composition for treating respiratory diseases
IL51043A0 (en) Novel pharmaceutical compositions comprising ergot-type compounds
IL49942A0 (en) Secondary acyloxy compounds,their manufacture and pharmaceutical compositions containing them